Methanolic Extract of Musa sapientum (L var. paradisiaca) Sucker Improves Lipid Profiles in Alloxan Induced Diabetic Rats
Alterations in plasma lipid profiles are common occurrences in diabetes. There
is also a positive correlation between the risk of developing ischaemic heart
disease and raised plasma cholesterol and LDL-cholesterol. Musa sapientum
sucker extract has proven to be an effective antidiabetic agent by lowering
blood sugar level and improve the islets of Langerhans. In this study, effect
of different concentrations of methanolic extracts of Musa sapientum
sucker on plasma lipid profile were assessed in alloxan induced diabetic rats.
Total plasma cholesterol, HDL cholesterol and triglyceride were determined using
enzymatic kits, while plasma LDL cholesterol, VLDL cholesterol, atherogenic
and coronary risk indices were calculated. The extract at 5 mg and 10 mg/kg/body
weight/day reduced significantly (p<0.05) the total plasma cholesterol, very
low density lipoprotein cholesterol and plasma triglyceride. Administration
of the extract also reduced significantly (p<0.05) the atherogenic and coronary
risk indices. However, a significant increase (p<0.05) was observed in plasma
HDL cholesterol. The result of the study indicates that Musa sapientum
sucker extract was effective in improving plasma lipid profile associated with
cardiovascular risk factors in alloxan induced diabetic rats.
Received: July 26, 2012;
Accepted: September 11, 2012;
Published: October 13, 2012
Diabetes mellitus is a non communicable disease, which is considered one of
the five leading causes of death in the world (Kumar et
al., 2007). It is a complex disease associated with myriad of debilitating
complications among which cardiovascular diseases are on a resounding note.
About 70 to 80% of death in diabetic patients are due to vascular diseases (Chattopadhyay
and Bandyopadhyay, 2005).
Cardiovascular diseases (CVD) contributed to one third of all global death
with developing countries, low income and middle income countries accounting
for 86% of disability-adjusted life years (WHO/FAO, 2003).
Some of the risk factors implicated in cardiovascular disease are: total plasma
cholesterol (Richard et al., 1989; Mazier
and Jones, 1991), Plasma triglycerides (Austin et
al., 2000; Van Lennep et al., 2002),
plasma LDL cholesterol (Singh et al., 2007),
plasma VLDL cholesterol (Rosenfeld et al., 1987;
Yla-Herttuala et al., 1989), plasma HDL cholesterol,
(APCSC, 2004; Barter, 2005),
coronary risk index (Alladi et al., 1989) and
atherogenic risk index (Abbot et al., 1988).
Musa sapientum belongs to the family Musaceae (Dhanabal
et al., 2005). It is one of the plants whose usefulness in ethnopractice
has been well documented (Mallick et al., 2006;
Pari and Umamaheswari, 2000; Best
et al., 1984; Kalash et al., 1993).
Different parts of Musa sapientum extract has been reported to posses
anti diabetic activity. Study on the antidiabetic effect of the plant has been
focused on the flower and fruits (Singh et al., 2007;
Lewis et al., 1999).
Previous reports have also indicated that cardiovascular diseases induced by
hyperglycaemia are associated with alteration in serum lipid profile (Laakso,
1996; Steiner, 1999; Massing
et al., 2001). Hence, if these risk factors are not controlled in
diabetic subjects, cardiovascular disease is imminent. In our previous study,
we reported that methanolic extract of Musa sapientum sucker possess
anti-hyperglycemic activity (Salau et al., 2010)
and thus could serve as a good phytomedicine for diabetic treatment. In this
study the effects of methanolic extract of Musa sapientum sucker on plasma
lipid profile changes in alloxan induced diabetic rats was investigated with
a view to finding its possible effects on cardiovascular disease induced by
MATERIALS AND METHODS
Plant materials and preparation of extracts: Ten kilogram of fresh Musa
sapientum sucker was harvested from a local garden in Ikenne, Ogun State,
Nigeria in 2008. The plant was identified and authenticated at the Forestry
Research Institute, Ibadan, Nigeria where a voucher number FHI 108349 was assigned.
Samples of the plant were deposited at the Herbarium. The sucker was cleaned
and rinsed in water to remove dirt. It was then dried at room temperature for
24 h. The sucker was thereafter cut into pieces and air dried (24-25°C).
Exactly 200 g of the pulverized sucker was soaked in 70% methanol for 48 h.
The extract was filtered and then concentrated with rotary evaporator. The concentrated
extract was then dried at room temperature. The dried product was kept in a
hermetically sealed container and stored in a desiccator. The required dose
of the extract was reconstituted in water daily and administered to the rats.
The yield of the extract was 2.61%.
Experimental subject and management: Forty rats (male and female) weighing
between 160-185 g were obtained from physiology Department, University of Ibadan
Nigeria. The rats were acclimatized for two weeks in an individual metabolic
cage and later divided randomly into four groups. They were all allowed access
to food and clean drinking water ad libitum. The care of the animals was in
accordance with the US Public Health Service Guidelines (NRC,
1999) and approved by the Olabisi Onabanjo University College of Health
Sciences and Animal ethics Committee.
Induction of diabetes: After the initial acclimatization period, 8 of
the rats were randomly selected into a group labeled G1 (normal control). Alloxan
(180 mg kg-1 b.wt. i.p.) was then administered into all other rats.
Exactly 72 h after alloxan administration, fasting blood glucose level of all
the rats were determined. Rats with fasting blood glucose level ≥300 mg dL-1
were then randomized into 3 groups of 8 rats each. The groups were labeled G2-G4
and treated as follow:
||Diabetic control: Administered with normal saline
||Test group 1: Administered with 5 mg kg-1 b.wt. of sucker
||Test group 2: Administered with 10 mg kg-1 b.wt. of
All administration was done orally as a single dose using an oral intubator.
Treatments were carried out for 8 weeks after which the rats were fasted over
night; blood was then withdrawn by cardiac puncture into lithium heparinized
bottle after anesthesia. The blood was centrifuged at 3,000 rpm for twenty minutes
and the plasma was collected.
Biochemical analysis: Plasma cholesterol, HDL cholesterol and Plasma
triglycerides were determined by enzymatic method using Randox kits. LDL cholesterol
was obtained by deduction using Friedwald equation. Atherogenic index was calculated
using the formula of Abbot et al. (1988). Coronary
risk index was determined the by method of Alladi et
al. (1989). VLDL cholesterol was estimated by dividing plasma triglyceride
Statistical analysis: The data were analyzed using one-way ANOVA. Level
of significance was assessed using Duncan Multiple Range Test (DMRT) at p<0.05
(SPSS 14.0 software was used for data analyses).
The result of the plasma lipoprotein indicates that alloxan administration
significantly increased (p<0.05) plasma total cholesterol level above the
normal control value (Table 1). Treatment with methanolic
sucker extract at the two tested doses brought the total cholesterol level to
the pretreatment level. No significant variation (p>0.05) was observed in
the total plasma cholesterol level at the two tested doses. Triglyceride level
was also observed in the study to increase with alloxan treatment. When the
extracts were administered to the diabetic rats (G3 and G4) the triglyceride
level was reduced significantly (p<0.05) below the pretreatment level. The
triglyceride level of 67.65±4.03 mg dL-1 observed in rats
treated with 10 mg kg-1 which was significantly (p<0.05) lower
than that observed in rats treated with 5 mg kg-1 dose. No significant
difference (p>0.05) was observed in HDL cholesterol level of untreated diabetic
rats and those treated with the extract at the two tested doses; however a significant
increase (p<0.05) was observed in the HDL cholesterol when compared with
the normal control (G1). No significant variations (p>0.05) were observed
in the HDL cholesterol levels at the two treated doses. A significant increase
in plasma LDL cholesterol from 38.92±2.25 mg dL-1 in the normal
control to 80.83±0.43 mg dL-1 was observed after alloxan administration.
Treatment with the extract however, brought the LDL cholesterol level to the
|| Effect of Musa sapientum sucker extract on plasma
lipids in normal and alloxan-induced diabetic rats
|Mean±SEM for 8 rats per group, Values within a column
with different superscripts are significantly different at p<0.05 (DMRT)
|| Effect of Musa sapientum sucker extract on risk indices
in normal and alloxan-induced diabetic rats
|Values are Mean±SEM for 8 rats per group, Values within
a column with different superscripts are significantly different at p<0.05
The observed LDL cholesterol of 39.80±4.23 mg dL-1 in rats
treated with 5 mg kg-1 dose of the extract was not different (p>0.05)
from the value of 34.20±2.26 mg dL-1 observed in the group
treated with 10 mg kg-1 dose. VLDL cholesterol was also observed
to be significantly raised (p<0.05) with alloxan administration whereas treatment
with the extract reduced the VLDL level to values lowered than the normal control
The results of the effect of treatment on coronary and atherogenic risk indices
are shown in Table 2. Administration of alloxan increased
both the coronary and atherogenic risk indices significantly (p<0.05). Treatment
with Musa sapientum sucker extract at the two tested doses however lowers
the coronary risk index (5.4±0.11 to 2.93±0.23) and atherogenic
risk index (3.02±0.08 to 1.39±0.19). The atherogenic risk indices
at the two tested doses (1.39±0.19) and (1.18±0.12) were not different
from the normal control group (1.66±0.15), however, the coronary risk
index was observed to be lower (2.62±0.17) than the value in the normal
control group (3.50±0.18). No significant difference (p>0.05) was
however observed in these parameters at the two tested doses.
Many investigators have reported on the effect of plant extracts on serum lipids.
Karimi and Hayatghaibi (2006) reported whole hemp seed,
significantly reduced serum LDL. Chattopadhyay and Bandyopadhyay
(2005) reported the effect of Azadirachta indica leaf extract on
serum lipid profile of streptozotocin-induced diabetic rats. The extracts significantly
reduced total cholesterol, LDL and VLDL cholesterol while HDL cholesterol remained
unchanged. Ethanolic and methanolic extracts of Musa sapientum sucker
extracts have been reported to possess anti-hyperglycaemic effect in alloxan
induced diabetic rats (Salau et al., 2010; Gorinstein
et al., 2007). Alterations in plasma lipid profiles are common occurrence
in diabetics, which are likely to increase cardiovascular disease (Pari
and Umamaheswari, 2000; Kalash et al., 1993;
Steiner, 1999), thus improvement in plasma lipid profiles
could be considered as beneficial in the treatment of the disease. This study
shows that methanolic extract of Musa sapientum improves lipid profile
in alloxan induce diabetic rats.
The preliminary phytochemical analysis of Musa sapientum revealed the
presence of saponins, saponin-glucosides, tannins, alkaloids and indole alkaloids.
It is opined that these compounds, either singularly or synergistically might
be responsible for the moderating effect observed in the lipid profile. One
of the plausible mechanisms could be as a result of normalization of blood glucose
via restoration of pancreatic integrity which was adversely affected by alloxan
(Salau et al., 2010). Thus, it can be opined
from the findings in the present study that the raised levels of total plasma
cholesterol, plasma triglycerides, LDL and VLDL cholesterols that were associated
with diabetes could be lowered with methanolic extract of Musa sapientum
suckers. Similarly, this study indicates that increase in HDL cholesterol occurs
along with concomitant decreases on other plasma lipoproteins when diabetics
are treated with Musa sapientum extract. This is indicative of cardioprotective
effects (Rosenfeld et al., 1987; Mazier
and Jones, 1991; Oke et al., 1999; Austin
et al., 2000; Van Lennep et al., 2002)
hence, present results suggest that administration of Musa sapientum
sucker extract in diabetics has cardioprotective effect. The result of this
study also suggests that the antihyper-triglyceridaemic effect of the extract
might not be dose dependent with respect to total cholesterol, HDL cholesterol,
LDL cholesterol, coronary and atherogenic indices.
The present study indicates that Musa sapientum suckers contain compounds
that have a protective mechanism against the development of atherosclerosis
through lipid profiles moderation. Our investigation thus suggest that methanolic
extracts of Musa sapientum suckers may be helpful in controlling hyperlipidaemia
as well as atherosclerosis in Insulin Dependent Diabetes Mellitus (IDDM).
1: Abbott, R.D., P.W.F. Wilson, W.B. Karvel and W.P. Castelli, 1988. High density lipoprotein cholesterol, total cholesterol screening and myocardial infarction. The Framingham study. Arteriosclerosis, 8: 207-211.
CrossRef | PubMed |
2: Alladi, S., A. Khada and M. Shanmugan, 1989. Induction of hypercholesterolemia by simple soil protein with acetate generating amino acid. Nutr. Rep. Int., 40: 893-894.
3: APCSC, 2004. Preventive cardiology: Serum triglycerides as a risk factor for cardiovascular disease in the Asia-Pacific Region. Circulation, 110: 2678-2686.
Direct Link |
4: Austin, M.A., B.L. Rodrignez, B. McKnight, M.J. McNeely, K.L. Edwards, J.D. Curb and D.S. Sharp, 2000. Low density lipoprotein particle size triglycerides and high density lipoprotein as risk factors for coronary heart disease in older Japanese-American men. Am. J. Cardrol., 86: 412-416.
5: Barter, P., 2005. The role of HDL cholesterol in preventing atherosclerotic disease. Eur. Heart J., 7: F4-F8.
CrossRef | Direct Link |
6: Best, R., D.A. Lewis and N. Nasser, 1984. The anti-ulcerogenic activity of the unripe plantain banana (Musa species). Br. J. Pharmacol., 82: 107-116.
PubMed | Direct Link |
7: Chattopadhyay, R.R. and M. Bandyopadhyay, 2005. Effect of Azadirachta indica leaf extract on serum lipid profile changes in normal and streptozotocin induced diabetic rats. Afr. J. Biomed. Res., 8: 101-104.
CrossRef | Direct Link |
8: Dhanabal, S.P., M. Sureshkumar, M. Ramanathan and B. Suresh, 2005. Hypoglycemic effect of ethanolic extract of Musa sapientum on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential. J. Herb Pharmacother., 5: 7-19.
PubMed | Direct Link |
9: Gorinstein, S., H. Leontowicz, M. Leontowicz, R. Krzeminski and R. Gralak et al., 2007. Effect of hesperidin and naringin on the plasma lipid profile and plasma antioxidant activity in rats fed a cholesterol-containing diet. J. Sci. Food Agric., 87: 1257-1262.
10: Prasad, K.V., K. Bharathi and K.K. Srinivasan, 1993. Evaluation of Musa paradisiaca Linn cultivar. Puttable stem juice for antilithiatic activity in albino rats. Indian J. Physiol. Pharmacol., 37: 337-341.
11: Karimi, I. and H. Hayatghaibi, 2006. Effect of Cannabis sativa L. seed (hempseed) on serum lipid and protein profiles of rat. Pak. J. Nutr., 5: 585-588.
CrossRef | Direct Link |
12: Kumar, G., S.G. Banu, A.G. Murugesan and R.M. Pandian, 2007. Antihyperglycaemic and antiperoxidative effect of Helicteres isora L. bark extracts in streptozotocin-induced diabetic rats. J. Applied Biomed., 5: 97-104.
Direct Link |
13: Laakso, M., 1996. Lipids and Lipoproteins as risk factors for coronary heart disease in non-insulin dependent diabetes mellitus. Ann. Med., 28: 341-345.
14: Lewis, D.A., W.N. Fields and G.P. Shaw, 1999. A natural flavonoid present in unripe plantain banana pulp (Musa sapientum var. paradisiaca) protects the gastric mucosa from aspirininduced erosions. J. Ethnopharmacol., 65: 283-288.
15: Mallick, C., R. Maiti and D. Ghosh, 2006. Comparative study on antihyperglycemic and antihyperlipidemic effect of separate and composite extract of seed of Eugenia jambolana and root of Musa paradisiaca in streptozotocin induced diabetic male albino rat. Iran. J. Pharmacol. Ther., 5: 27-33.
Direct Link |
16: Massing, M.W., C.A. Sueta, M. Chowdhury, D.P. Biggs and R.J. Simpson Jr., 2001. Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. Am. J. Cardiol., 87: 646-649.
17: Mazier, M.J. and J.H. Jones, 1991. Dietary fat quality and circulating cholesterol levels in humans: A review of actions and mechanisms. Prog. Food Nutr. Sci., 15: 21-41.
18: NRC, 1999. Guide for the Care and Use of Laboratory Animals. 2nd Edn., National Academy Press, Washington, DC., USA., pp: 54-63
19: Oke, J.M., C.J. Achife and O.O. Adefisan, 1999. Hypoglycemic activity of the alcoholic extract of Musa sapientum. Niger. J. Nat. Prod. Med., 3: 68-70.
Direct Link |
20: Pari, L.J. and J. Umamaheswari, 2000. Antihyperglycaemic activity of Musa sapientum flowers: Effect on lipid peroxidation in alloxan diabetic rats. Phytother. Res., 14: 136-138.
CrossRef | Direct Link |
21: Richard, E.G., S.M. Grundy and K. Coper, 1989. Influences of plasma triglycerides on lipoprotein patterns in normal subjects and in patient with coronary artery disease. Am. J. Cardiol., 63: 1214-1220.
22: Rosenfeld, M.E., T. Tsukada, A.M. Gown and R. Ross, 1987. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis, 7: 9-23.
CrossRef | Direct Link |
23: Salau, B.A., E.O. Ajani, A.A. Akinlolu, M.N. Ekor and M.O. Soladoye, 2010. Methanolic extract of Musa sapientum sucker moderates fasting blood glucose and body weight of alloxan induced diabetic rats. Asian J. Exp. Biol. Sci., 1: 30-35.
Direct Link |
24: Singh, S.K., A.N. Kesari, P.K. Rai and G. Watal, 2007. Assessment of glycemic potential of Musa paradisiaca stem juice. Indian J. Clin. Biochem., 22: 48-52.
25: Steiner, A., 1999. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities. Diabetes Care, 22: C6-C9.
26: Van Lennep, J.E.R., T.H. Westerveld, W.D. Erlcelens and E.E. van der Wall, 2002. Risk factor for coronary heart disease: Implications of gender. Cardiovasc. Res., 53: 538-549.
Direct Link |
27: WHO/FAO, 2003. Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series No. 797, World Health Organization, Geneva.
28: Yla-Herttuala, S., W. Palinski, M.E. Rosenfeld, S. Parthasarathy and T.E. Carew et al., 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest., 84: 1086-1095.